Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Gagelmann N, Badbaran A, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Wolschke C, Robin M, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N.
Gagelmann N, et al. Among authors: cassinat b.
Blood. 2023 Jun 8;141(23):2901-2911. doi: 10.1182/blood.2023019630.
Blood. 2023.
PMID: 36940410
Free PMC article.